BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30349062)

  • 1. LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications.
    Han YJ; Boatman SM; Zhang J; Du XC; Yeh AC; Zheng Y; Mueller J; Olopade OI
    Sci Rep; 2018 Oct; 8(1):15572. PubMed ID: 30349062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
    Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
    Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
    Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
    Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer.
    Tracy KM; Tye CE; Ghule PN; Malaby HLH; Stumpff J; Stein JL; Stein GS; Lian JB
    Mol Cancer Res; 2018 Apr; 16(4):587-598. PubMed ID: 29378907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
    Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
    Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
    Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; ; Xie W; Yang D
    Cancer Cell; 2018 Apr; 33(4):706-720.e9. PubMed ID: 29622465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
    Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
    Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
    Sas-Chen A; Aure MR; Leibovich L; Carvalho S; Enuka Y; Körner C; Polycarpou-Schwarz M; Lavi S; Nevo N; Kuznetsov Y; Yuan J; Azuaje F; ; Ulitsky I; Diederichs S; Wiemann S; Yakhini Z; Kristensen VN; Børresen-Dale AL; Yarden Y
    EMBO Mol Med; 2016 Sep; 8(9):1052-64. PubMed ID: 27485121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.
    Lawson CD; Fan C; Mitin N; Baker NM; George SD; Graham DM; Perou CM; Burridge K; Der CJ; Rossman KL
    Cancer Res; 2016 Jul; 76(13):3826-37. PubMed ID: 27216196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
    She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
    BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
    Giro-Perafita A; Luo L; Khodadadi-Jamayran A; Thompson M; Akgol Oksuz B; Tsirigos A; Dynlacht BD; Sánchez I; Esteva FJ
    NPJ Breast Cancer; 2020; 6():1. PubMed ID: 31934613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.
    Heilmann K; Toth R; Bossmann C; Klimo K; Plass C; Gerhauser C
    Oncogene; 2017 Nov; 36(46):6446-6461. PubMed ID: 28759043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
    Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
    Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal-like Breast Cancer.
    Zhang J; Miao N; Lao L; Deng W; Wang J; Zhu X; Huang Y; Lin H; Zeng W; Zhang W; Tan L; Yuan X; Zeng X; Zhu J; Chen X; Song E; Yang L; Nie Y; Huang D
    Adv Sci (Weinh); 2024 May; 11(20):e2307660. PubMed ID: 38491910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Transcript Variant 6 of
    Zhang X; O'Brien D; Zhang X
    Oxid Med Cell Longev; 2022; 2022():7078787. PubMed ID: 36071863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-cadherin and vimentin are useful basal markers in breast cancers.
    Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
    Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.